T-cell chronic lymphocytic leukemia: T-cell function and lymphokine secretion
✍ Scribed by Syed Raziuddin; Anwar Sheikha; Abdulbasit A. Latif
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 692 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The leukemic T‐celis of the six patients with T‐cell chronic lymphocytic leukemia (T‐CLL), four with CD4 and CD45R‐positive (CD4+ CD45R*) T‐CLL and two with CD8 and CD45R‐positive (CD8+ CD45R+) T‐CLL pheno‐type were studied for detailed immunologic phenotypic and functional characteristics. The levels of soluble in‐terleukin‐2 receptors were elevated significantly in the serum of all four patients with CD4+ CD45R+ T‐CLL. Moreover, the CD4+ CD45R+ T‐CLL patients' T‐cells, after in vitro stimulation with phytohemagglutinin and concanavalin A, expressed elevated percentages of interieukin‐2 receptors on cells and secreted high interleukin‐2 activity. The B‐cell growth factor (BCGF) activity from three patients with CD4+ CD45R+ T‐CLL was enhanced, but B‐cell differentiation factor (BCDF) activity of the all T‐CLL patients was decreased. Reduced BCGF and BCDF activity of the leukemic T‐cells was one possible mechanism of hypogammaglobulinemia detected in two patients with T‐CLL. All T‐CLL patients' leukemic T‐cells had diminished immunoregulatory functional activity in allogeneic mixed lymphocyte reactions. These observations suggest that leukemic T‐cells from T‐CLL patients have many immunologic functional defects that may be important in their proliferative potential.
📜 SIMILAR VOLUMES
The humoral antibody immunodeficiency in two patients with T-cell chronic lymphocytic leukemia (T-CLL) appeared to be the result of immunoregulatory abnormalities in the leukemic T-cell populations. Both patients had CD4-t CD45RS "virgin" or suppressor-inducer T-CLL, but Patient 1 had hypogammaglobu
## Abstract Adult T‐cell leukemia/lymphoma (ATLL) patients are highly immunocompromised, but the underlying mechanism responsible for this state remains obscure. Recent studies demonstrated that __FOXP3__, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed